
Season 2 Teaser
02/12/24 • 2 min
We start the second season of this series with an update on what you can expect from new episodes, which start to drop soon.
Your host, Steve Lewis, shares details on changes you can expect as the series evolves. One change will be a broadening of application topics to be covered, as this season will include episodes discussing transcriptomics in biopharma, the use of molecular biology by CROs, brewing, food testing, food production, biosecurity, and non-bench careers that use molecular biology. Steve reassures that all episodes, however, are squarely focused on the role that molecular biology plays in driving the innovative work of each guest forward.
Get ready for some great conversations coming your way soon, and don’t forget to catch up on any missed episodes from last season!
Subscribe to get future episodes as they drop and if you like what you’re hearing we hope you’ll share a review or recommend the series to a colleague.
Visit the Invitrogen School of Molecular Biology to access helpful molecular biology resources and educational content, and please share this resource with anyone you know working in molecular biology.
For Research Use Only. Not for use in diagnostic procedures.
We start the second season of this series with an update on what you can expect from new episodes, which start to drop soon.
Your host, Steve Lewis, shares details on changes you can expect as the series evolves. One change will be a broadening of application topics to be covered, as this season will include episodes discussing transcriptomics in biopharma, the use of molecular biology by CROs, brewing, food testing, food production, biosecurity, and non-bench careers that use molecular biology. Steve reassures that all episodes, however, are squarely focused on the role that molecular biology plays in driving the innovative work of each guest forward.
Get ready for some great conversations coming your way soon, and don’t forget to catch up on any missed episodes from last season!
Subscribe to get future episodes as they drop and if you like what you’re hearing we hope you’ll share a review or recommend the series to a colleague.
Visit the Invitrogen School of Molecular Biology to access helpful molecular biology resources and educational content, and please share this resource with anyone you know working in molecular biology.
For Research Use Only. Not for use in diagnostic procedures.
Previous Episode

A look into the fruit bowl of biology
In this episode of Speaking of Mol Bio, we speak with Dr. Mandovi Chatterjee about single cell analysis. Dr. Chatterjee is the Director of Single Cell Core at Harvard University Medical School. She has spent her career at the exploring and mastering a wide variety of single cell methods . In conversation with Dr. Chatterjee, our hosts dive into the more technical aspects of this ever-evolving field. We also learn an interesting analogy to better understand the difference between bulk and single cell RNA sequencing. Subscribe to get future episodes as they drop and if you like what you’re hearing we hope you’ll share a review or recommend the series to a colleague. Visit the Invitrogen School of Molecular Biology to access helpful molecular biology resources and educational content, and please share this resource with anyone you know working in molecular biology. For Research Use Only. Not for use in diagnostic procedures.
Next Episode

High-throughput transcriptomics and AI for drug discovery
Doing something complex and meaningful in a new way requires thinking and acting a bit differently. This is the case with how Dr. Joey Azofeifa, from Arpeggio Bio, is using systems biology to discover new drug candidates.
Join us in this Season 2 kickoff episode where we dive headlong into transcriptomics, systems biology, machine learning, and learn how they’re being used to innovate drug discovery. We learn about 3’-end mRNA barcoding and in-cell reverse transcription methods that allow the pooling of up to 1,536 samples so that only a single library preparation is required while still allowing the deconvolution of RNAseq results. This reduces their RNAseq costs by up to 400-fold, which enables them to generate enormous transcriptomic data sets. We also learn about how they’re using generative adversarial AI networks to use this transcriptomics data to design potential drug candidates. We even hear how one of their drug candidates, which targets iron homeostasis pathways, has progress to successful testing in mice.
To access the transcript for download, please visit - https://www.thermofisher.com/us/en/home/brands/invitrogen/molecular-biology-technologies/speaking-of-mol-bio-podcast.html
Subscribe to get future episodes as they drop and if you like what you’re hearing we hope you’ll share a review or recommend the series to a colleague.
Visit the Invitrogen School of Molecular Biology to access helpful molecular biology resources and educational content, and please share this resource with anyone you know working in molecular biology.
For Research Use Only. Not for use in diagnostic procedures.
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/speaking-of-mol-bio-520211/season-2-teaser-67820098"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to season 2 teaser on goodpods" style="width: 225px" /> </a>
Copy